Inflammatory biomarkers in the young stroke population

Main Article Content

Mustafa Emir Tavşanlı
Elif Ünal

Abstract

Objective: Studies showed that cerebral ischemia due to arterial occlusion is related to local inflammation. Neutrophil to Lymphocyte Ratio (N/L)  and Monocyte to high density lipoprotein Cholesterol  Ratio (M/H) are two biomarkers that are shown to be increased in inflammation. These biomarkers can be used to determine the risk for atherosclerotic ischemic stroke. Increased Homocysteinemia  (Hcy) is also a risk factor for ischemic stroke, especially in the young population. There is insufficient data in the literature about the correlation of these biomarkers in young stroke patients.


We aimed to show if these biomarkers can be related to atherothrombotic cerebrovascular disease in the young population to provide information for young people to stroke risk.


Study design and method: This retrospective study included 43 atherosclerotic ischemic young stroke patients,  age between 18- 55 years and age/ gender matched 42 healthy control group.  Control group were enrolled from patients who were admitted to our outpatient clinics with headaches, having normal examinations and no other diseases.  


Results: The ratios of N/L  and M/H  were both higher in the stroke group (p=0.008 and p=0.011 respectively), but the gender subanalysis showed there was no significance in the males. When the patients were sub-grouped as having hyper Hcy or not; these ratios did not show any significance.


Conclusion: Inflammatory biomarkers should be interpreted carefully by concerning the age and the gender of the patients. Further studies with large sample groups are necessary for the biomarkers of young stroke population.

Downloads

Download data is not yet available.

Article Details

How to Cite
TavşanlıM. E., & ÜnalE. (2020). Inflammatory biomarkers in the young stroke population. Medical Science and Discovery, 7(9), 642-646. https://doi.org/10.36472/msd.v7i9.419
Section
Research Article

References

1. Johnson W, Onuma O, Owolabi M, Sachdev S. Stroke: A global response is needed Bull. World Health Organ. 2016; 94 (9): 634A-635A doi: 10.2471/BLT.16.181636.

2. Kissela BM, Khoury JC, Alwell K, Moomaw JC, Woo D, et al. Age at stroke. Neurol. 2012; 79 (17): 1781-1787 doi: 10.1212/WNL.0b013e318270401d

3. Sarecka-Hujar B, Kopyta I. Risk factors for recurrent arterial ischemic stroke in children and young adults. Brain Sci. 2020; 10 (1): 1-20 doi: 10.3390/brainsci 10010024.

4. Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005; 76 (2): 191-195 doi: 10.1136/jnnp.2004.040543.

5. Gang L, Yanyan Z. Increased neutrophil to lymphocyte ratio in persons suffering from hypertension with hyperhomocysteinemia. Hypertens. Res. 2016; 39 (8): 606-611 doi: 10.1038/hr.2016.30.
6. Celikbilek A, Ismailogullari S, Zararsiz G. Neutrophil to lymphocyte ratio predicts poor prognosis in ischemic cerebrovascular disease. J. Clin. Lab. Anal. 2014; 28 (1): 27-31 doi: 10.1002/jcla.21639.

7. Wang P, Kao C, Mui M, Wang S. Leukocyte Infiltration in Acute Hemispheric Ischemic Stroke. Stroke. 1993; 24 (2): 236-240

8. Imtiaz F, Shafique K, Mirza S, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int. Arch. Med. 2012; 5 (1): 2 doi: 10.1186/1755-7682-5-2.

9. Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int. Urol. Nephrol. 2014; 46 (8): 1619-1625 doi: 10.1007/s11255-014-0730-1.

10. Çiçek G, Kundi H, Bozbay M, Yayla C, Uyarel H. The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI. Coron. Artery Dis. 2016; 27 (3): 176-184. doi: 10.1097/MCA.0000000000000343.

11. Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res. Notes. 2017; 10(1): 1-4 doi: 10.1186/s13104-016-2335-5.

12. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med.1991; 324 (17): 1149-1155 doi: 10.1056/NEJM199104253241701.















13. Tan K, Toong-chow L, Tan C. Hyperhomocysteinemia in patients with acute ischaemic stroke in Malaysia. Neurol J Southeast Asia. 2001; 6: 113-119

14. Wang HY, Shi WR, Yi X, Zhou YP, Wang ZQ, Sun YX. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: Insights from a population-based Chinese cohort. Lipids Health Dis. 2019; 18 (1): 1-11 doi: 10.1186/s12944-019-1076-6.

15. Lee JS, Kim NY, Na SH, Youn YH, Shin CS. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Med. (United States). 2018; 97 (26): 1-5 doi: 10.1097/MD.0000000000011138.

16. Wu L, Zou S, Wang C, Tan X, Yu M. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China. BMC Cardiovasc. Disord. 2019; 19 (1): 1-5 doi: 10.1186/s12872-019-1110-7.

17. Meng X, Chang Q, Liu Y, Chen L, Wei G,Yang J, et al. Determinant roles of gender and age on SII, PLR, NLR, LMR and MLR and their reference intervals defining in Henan, China: A posteriori and big-data-based. J. Clin. Lab. Anal. 2018; 32 (2): 1-8 doi: 10.1002/jcla.22228.

18. Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, et al. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood.,2003; 102 (7): 2653-2659 doi: 10.1182/blood-2003-02-0649.

19. Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, et al. Effects of Gender on White Blood Cell Populations and Neutrophil-Lymphocyte Ratio Following Gastrectomy in Patients with Stomach Cancer. J. Korean Med. Sci. 2007; 22 (Suppl): S104-S108 doi: 10.3346/jkms.2007.22.s.s104.

20. Libby P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012; 32 (9): 2045-2051 doi: 10.1161/ATVBAHA.108.179705.

21. Schaftenaar F, Frodermann V, Kuiper J, Lutgens E. Atherosclerosis: the interplay between lipids and immune cells. Curr. Opin. Lipidol. 2016; 27 (3): 209-215 doi: 10.1097/MOL.0000000000000302.

22. Niazi F, Aslam A, Khattak S, Waheed S. Frequency of Homocysteinemia in Young Ischemic Stroke Patients and Its Relationship with the Early Outcome of a Stroke. Cureus. 2019; 11(9): 1-10 doi: 10.7759/cureus.5625.

23. Ashjazadeh N, Fathi M, Shariat A. Evaluation of homocysteine level as a risk factor among patients with ischemic stroke and its subtypes. Iran. J. Med. Sci. 2013; 38 (3): 233-239